Mitomycin-C-loaded alginate carriers for bladder cancer chemotherapy: In vivo studies

Journal of Bioactive and Compatible Polymers

Volumn 20, Issue 2, 2005, Pages 197-208

  Eroǧlu, Muzaffer ^a   Öztürk, Eylem ^b   Özdemýr, Nalan ^b   Denkbap, Emýr Baký ^b   Doǧan, Işin ^b   Acar, Abuzer ^c   Güzel, Murat ^c  

^a SSK Ihtisas Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Alginate; Bladder cancer; Controlled release; Mitomycin C; Transurethral resection (TUR)

Indexed keywords

BIOPOLYMERS; CHEMOTHERAPY; CROSSLINKING; ETHERS; LIVING SYSTEMS STUDIES; PRECIPITATION (CHEMICAL); TISSUE;

ETHYLENE GLYCOL; MUCOADHESIVE POLYMERS; TRANSURETHRAL RESECTION (TUR); TUMROAL TISSUE;

TUMORS;

ALGINIC ACID; DRUG CARRIER; ETHYLENE GLYCOL DERIVATIVE; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; BLADDER CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; ECHOGRAPHY; HISTOPATHOLOGY; IMMUNOTHERAPY; NONHUMAN; PRECIPITATION; RABBIT; TRANSURETHRAL RESECTION;

EID: 17444379697     PISSN: 08839115     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883911505051853     Document Type: Article

References (17)

1. Case, R.A.M., Hosker, M.E., McDonald, D.B. and Pearson, J.T. (1954). Tumours of the Urinary Bladder in Workmen Engaged the Manufacture and the Use of Certain Dyestuff Intermediates in the British Chemical Industry: Role of Aniline, Benzidine, Alpha-naphthylamine, Br. J. Ind. Me., 11: 75.
2. Wynder, E.L. and Goldsmith, R. (1977). The Epidemiology of Bladder Cancer: A Second Look, Cancer, 40: 1246.
3. Thompson, I.M., Peek, M. and Rodriguez, F.R. (1987). The Impact of Cigarette Smoking on Stage, Grade and Number of Recurrences of Transitional Cell Carcinoma of the Bladder, J. Urol., 137: 401.
4. Prout Jr, G.R. (1976). The Surgical Management of Bladder Carcinoma, Urol. Clin. N. Am., 3: 149.
5. Lamm, D.L., Thor, D.E., Stogdill, V.D. and Radwin, H.M. (1982). Bladder Cancer Immunotherapy, J. Urol., 128: 931.
6. Catalona, W.J., Hudson, M.A., Gillen, D.P., Andriole, G.L. and Ratliff, T.L. (1987). Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder Cancer, J. Urol., 137: 220.
7. Highley, M.S., Oosterom, A.T., Maes, R.A. and Brujin, E.A. (1999). Intravesical Drug Delivery, Drug Deliv. Sys., 37: 59.
8. Smart, J.D. (1991). An In Vitro Assessment of Some Mucosa-adhesive Dosage Forms, Int. J. Pharm., 73: 69.
9. Denkbas, E.B., Eroǧlu, M., Acar, A., Özdemir, N. and Öztürk, E. (2004). Preparation and Characterization of Mitomycin-C Loaded Alginate Carriers for Superficial Bladder Cancer Chemotherapy, J. Bioact. Comp. Pol., 19: 1, 33.
10. Lehr, C.M., Bouwstra, J.A., Schacht, E.H. and Junginger, H.E. (1992). In Vitro Evaluation of Mucoadhesive Properties of Chitosan and Some Other Natural Polymers, Int. J. Pharm., 78: 43.
11. Wong, C.F., Yuen, K.H. and Peh, K.K. (1999). An In-vitro Method for Buccal Adhesion Studies: Importance of Instrument Variables, Int. J. Pharm., 180: 47.
12. Witschi, C. and Mrsny, R.J. (1999). In Vitro Evaluation of Microparticles and Polymer Gels for Use as Nasal Platforms for Protein Delivery. Pharmaceut. Res., 16: 382.
13. Eroǧlu, M., Irmak, S., Acar, A. and Denkbaş, E.B. (2002). Design and Evaluation of a Mucoadhesive Therapeutic Agent Delivery System for Postoperative Chemotherapy in Superficial Bladder Cancer, Int. J. Pharm., 235: 51.
14. Atala, A., Kim, W. and Paige, K.T. (1994). Endoscopic Treatment of Vesicoureteral Reflux with a Chondrocyte-alginate Suspension, J. Urol., 152: 641.
15. Diamond, D.A. and Caldamone, A.A. (1999). Endoscopic Correction of Vesicoureteral Reflux in Children Using Autologous Chondrocytes: Preliminary Results, J. Urol, 162(suppl.): 1185.
16. Atala, A. (2000). Tissue Engineering of Artificial Organs, J. Endourol, 14: 49.
17. Pariente, J.L., Kim, B.S. and Atala, A. (2002). In Vitro Biocompatibility Evaluation of Naturally Derived and Synthetic Biomaterials Normal Human Bladder Smooth Muscle Cells, J. Urol., 165:1867.